bharat biotech
-
Covaxin showed 81% efficacy in third phase trials, says Bharat Biotech
Scroll Staff
-
China-backed hackers targeted Indian vaccine manufacturers, says cyber-intelligence firm: Reuters
Scroll Staff
-
Coronavirus: Centre asks eight states reporting surge in cases to deal firmly with violations
Scroll Staff
-
Covid-19: Covaxin ‘safe and immunogenic’ says health minister after Chhattisgarh flags ‘inhibition’
Scroll Staff
-
Covaxin showed enhanced immune response, no major side effects, says Lancet study on Phase 1 trials
Scroll Staff
-
Coronavirus: Those with fever, allergies shouldn’t take Covaxin, says Bharat Biotech in fact sheet
Scroll Staff
-
Coronavirus: We prefer Covishield vaccine over Covaxin, say doctors at Delhi’s RML Hospital
Scroll Staff
-
Coronavirus: ‘Indians are not guinea pigs,’ says Manish Tewari, questions move to roll out Covaxin
Scroll Staff
-
In Bhopal, Covid-19 vaccine trial participants say they were misled
Anoo Bhuyan, IndiaSpend.com
-
Covid-19: Bharat Biotech sends first vaccine doses to 11 cities, day after Serum Institute rollout
Scroll Staff
-
Coronavirus: Centre to procure 55 lakh doses of Bharat Biotech’s vaccine
Scroll Staff
-
Coronavirus: Delhi reports 306 new cases, lowest since May
Scroll Staff
-
Stop Covaxin trial, Bhopal gas tragedy survivors’ organisations write to PM Narendra Modi
Scroll Staff
-
Coronavirus: Volunteer’s death not related to vaccine, says Bharat Biotech
Scroll Staff
-
Coronavirus: Bharat Biotech vaccine approved in clinical trial mode, clarifies ICMR
Scroll Staff
-
Coronavirus: Serum, Bharat Biotech pledge smooth rollout of vaccine a day after public spat
Scroll Staff
-
Bharat Biotech chief hits out at Serum Institute for claiming other Covid vaccines are ‘like water’
Scroll Staff
-
The big news: Centre-farmer talks fail again, next round on Friday, and nine other top stories
Scroll Staff
-
Coronavirus: India set to launch the world’s biggest vaccination programme, says PM Modi
Scroll Staff
-
Covid-19: Bharat Biotech MD asks for a week for confirmed data after row over third phase trials
Scroll Staff